Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Dec 15, 2011 · 10-Q · 45 days after period end · 0001354488-11-005021
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Revenue | $95.16K | $27.13K |
| Net Income | -$2.93M | $2.05M |
| EPS Diluted | -$0.29 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Oct 31, 2011 · filed Dec 15, 2011 · 45 d after period end
